ClearMargin is developing an endovascular tumor treatment for pancreatic cancer patients. Pancreatic cancer poses a formidable challenge in the medical field, necessitating innovative solutions. ClearMargin is developing a unique treatment designed to target pancreatic cancer with precision, addressing the urgent need for more effective interventions in this highly aggressive disease. This innovative approach offers a vital treatment option for a large patient population that currently has no alternatives.